Biologics Extremities Spine Sports Medicine Biocomposites to distribute its NanoBone® product range in the UK byJosh SandbergSeptember 12, 2024
Extremities Hospitals Spine Sports Medicine Biocomposites expands its international presence by opening new sales and distribution office in Italy byJosh SandbergJanuary 16, 2024
Biologics Spine Top Stories Biocomposites’ investee Renovos Biologics receives FDA Breakthrough Device Designation for its synthetic nanoclay bone fusion gel, RENOVITE® BMP-2 byJosh SandbergJanuary 4, 2024
Recon Biocomposites expands its product portfolio with the launch of SYNICEM™ spacers in the UK byJosh SandbergNovember 22, 2023
Biologics Financial Biocomposites invests in Renovos Biologics – developers of the RENOVITE® nanoclay therapeutic delivery platform byJosh SandbergJuly 6, 2023
Biologics Spine Sports Medicine Biocomposites adds proprietary NanoBone® technology to its portfolio through the acquisition of Artoss GmbH byJosh SandbergJune 6, 2023
Biologics Extremities Spine Sports Medicine Top Stories Biocomposites signs distribution agreement with NuVasive Specialized Orthopedics to supply STIMULAN® in Germany byJosh SandbergDecember 7, 2021
Biologics Biocomposites announces new approval for STIMULAN® to treat bacterial infection byChris StewartJuly 7, 2021
